ABSTRACT
INTRODUCTION
Based on the crucial role in energy production and homeostasis, mitochondria are key players in neuronal cell functions (1) . Due to high energy demand and low glycolytic capacity, neuronal cells are extremely dependent on their mitochondria and energy production. Accordingly, precise and coordinated control mechanisms adjust mitochondrial number, distribution, and function through a set of complex processes including mitochondrial fission and fusion, mitophagy and biogenesis (2, 3) . Mitochondrial biogenesis, generation of new mitochondria, which requires exquisite coordination of both nucleus and mitochondrial genome can be promoted by exercise, cold, oxidative stress, etc. (4) . As the master regulator of mitochondrial biogenesis, transcriptional coactivator peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) orchestrates variety of transcription factors including nuclear respiratory factor-1 (NRF-1) and NRF-2 and also mitochondrial transcription factor A (TFAM) (5-7). Mitochondria play multiple roles in oxido-redox state of cells by balancing detoxification and production of reactive oxygen species (ROS). In addition to intracellular organelles, it has been evidenced that nuclear factor (erythroid-derived 2)-like 1 and 2 (Nrf1 and Nrf2) belonging to the NF-E2 basic-leucine zipper family of proteins which coordinate antioxidant response to oxidative stress (8, 9) . Nrf2 as a transcription factor interacts with the antioxidant response element (ARE) in the upstream promotor region of many antioxidative genes leading to the promotion of the expression of detoxifying enzymes (10) (11) (12) . Recently, we reported that Nrf1 knockdown using a specific short interfering RNA molecule (siRNA) leads to alteration in protein level of mitochondrial biogenesis factors in hippocampus, amygdala, and prefrontal cortex of male rats (13) . Furthermore, we showed that Nrf2 knockdown induces anxiety-like behavior along with mitochondrial dysfunction and neuronal apoptosis in hippocampus, amygdala, and prefrontal cortex. However, the direct effect of Nrf2 silencing on mitochondrial biogenesis has remained unknown. Considering the fact that brain tissue function entirely depends on energy metabolism, tricarboxylic acid cycle (TCA) including eight pivotal enzymes could display rate changes of neuronal cells metabolism. Based on the given roles of mitochondria in glucose metabolism and modulatory function of Nrf2, present study was designed to figure out the effects of Nrf2 knockdown on protein level of mitochondrial biogenesis markers PGC-1α, NRF1, and TFAM along with the activities of TCA enzymes citrate synthase (CS) and malate dehydrogenase (MDH).
MATERIALS AND METHODS

ANIMALS
The experiments were carried out on male albino rats of Wistar strain weighing between 200 and 250 g at the beginning of the surgery. Animals were caged (four per cage) with free access to food and water and kept under constant environmental conditions (12 h-light-dark cycle with lights on from 07:00 to 19:00, at 20-22 °C room temperature). All experimental protocols and treatments were conducted in accordance with the Ethics Committee of Shahid Beheshti University of Medical Sciences.
EXPERIMENTAL DESIGN
Animals were randomly divided into 3 groups based on injection into dorsal third ventricle (D3V) (n=8). The experimental groups were as follows: control group 1 received 5 μl scrambled siRNA (this siRNA had no homology to any known mammalian gene); control group 2 received 5 μl RNase-free water and third group animals received 5 μl Nrf2-siRNA (5 nmol siRNA/200 μl RNAase-free water). Each group was assigned to two subgroups based on the time of decapitation (4 and 8 h after injection). Silencer select predesigned siRNA specific to Nrf2 was 5′-GCUGAA CUCCUUAGACUCAtt-3′ (ID: s136127) (Ambion, Austin, TX, USA) and scrambled siRNA was: 5′-UUCUCC GAACGUGUCACGUdTdT-3′ (QIAGEN Germany).
STEREOTAXIC SURGERY AND siRNA ADMINISTRATION IN RAT BRAIN
Surgical procedures were carried out as described previously (13) . Briefly, after general anesthesia, guide cannula was inserted into D3V (anteroposterior: -0.5 mm relative to bregma, mediolateral: 0 mm, and dorsoventral: -3 mm from the skull surface) (14) .
WESTERN BLOTTING
For molecular experiments, animals were decapitated and hippocampus, prefrontal cortex, and amygdala were dissected. Then, tissues were homogenized and protein concentration was measured using Bradford method (15) . Next, proteins were separated on SDS-PAGE and then transferred to Polyvinylidene fluoride membrane (Millipore, Billerica, MA, USA). Blots were blocked and then probed with specific primary antibodies against cytochrome c and β-actin from Cell Signaling Technology (Beverly, USA), PGC-1α from ABCAM (Cambridge, UK), NRF-1 from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and TFAM from BioVision (Palo Alto, CA, USA) overnight (1:1000 dilution) followed by incubation with horse radish peroxidase-conjugated secondary antibody. Immunoreactivity was visualized using the enhanced chemiluminescence method (Amersham Bioscience, Piscataway, USA). Finally, densitometric analysis of protein bands was done by Image J software.
MEASUREMENT OF CS ACTIVITY
Based on a method described by Craig (16) , CS activity was assayed. Briefly, protein extract was added to assay buffer containing Tris-HCl, Triton X-100, acetylCoA, 5-5ʹ-dithiobis (2-nitrobenzoic acid) and oxaloacetate. Alterations in the absorbance were recorded at 412 nm wavelength.
MDH ACTIVITY ASSESSMENT
To determine the activity of MDH, protein extract was added to mixture composed of oxaloacetate, Tris-HCl and NADH. Absorbance was measure at 340 nm, spectrophotometerically (16) (17) (18) .
DATA ANALYSIS
All experiments were executed (replicated) at least three times with consistent results. Data analysis was conducted by using Graphpad Prism® Software using a one-way analysis of variance (ANOVA) followed by the Tukey's test for multiple comparisons, where appropriate. The data are expressed as means ± SEM, and the level of statistical significance was considered when P-value < 0.05.
RESULTS
Nrf2 SILENCING LED TO DECREASE IN PROTEIN LEVEL OF UPSTREAM FACTOR PGC-1α IN HIPPOCAMPUS
As shown in Fig. 1 , intraventricular injection of Nrf2-siRNA significantly decreased protein level of PGC-1α compared to control rats in hippocampus region 4 and 8 h after injection. Despite the changes in PGC-1α level, as illustrated in Fig. 1C, 1D and 1E, mitochondrial biogenesis downstream molecules NRF-1, TFAM and cytochrome c did not significantly change following Nrf2 silencing in hippocampus 4 and 8 h after siRNA injection. 
PGC-1α BUT NOT ITS DOWNSTREAMS SIGNIFICANTLY DECREASED AFTER Nrf2-siRNA INJECTION IN PREFRONTAL CORTEX
As illustrated in Fig. 2 , Nrf2-siRNA injection decreased PGC-1α protein level in prefrontal cortex compared to the control group 4 and 8 h later. After 8 h, protein level of PGC-1α decreased 23% in comparison with control rats. Even though protein level of NRF-1 decreased in Nrf2-siRNA-injected rats 4 and 8 h after injection, these reductions were not statistically significant compared to control rats (Fig. 2C) . Furthermore, as shown in Fig. 2D and 2E, protein level of TFAM and cytochrome c did not show any significant alteration in Nrf2-siRNA injected rats in comparison with control group 4 and 8 h after injection. 
INTRAVENTRICULAR
INJECTION OF Nrf2-siRNA NOTABLY DECLINED PGC-1α PROTEIN LEVEL IN AMYGDALA As the master regulator of mitochondrial biogenesis, protein level of PGC-1α significantly decreased in amygdala 4 and 8 h after Nrf2-siRNA intraventricular injection (Fig. 3B) . Like the hippocampus and prefrontal cortex, decrease in protein level of NRF-1 was not significant compared to control group 4 and 8 h after Nrf2 silencing (Fig. 3C) . Also, protein level of TFAM and cytochrome c did not alter after Nrf2-siRNA injection as shown in Fig. 3D and 3E. 
Nrf2 SILENCING AFFECTED ACTIVITY OF TWO ENZYMES CS AND MDH IN HIPPOCAMPUS, PREFRONTAL CORTEX AND AMYGDALA
TCA cycle is an intra-mitochondrial series of enzyme-catalyzed chemical reactions that forms the central part of the aerobic respiration. Our data from biochemical assay indicated that activity of CS in hippocampus significantly increased in Nrf2-siRNA injected rats compared to control group (Fig. 4A) . Moreover, elevation in CS activity 4 h after siRNA injection was more. Interestingly, activity of MDH in hippocampus decreased significantly 4 and 8 h after Nrf2 silencing, as shown in Fig.  4B . Reduction in MDH activity after 8 h was more rather than 4 h. Measurement of activity of two enzymes CS and MDH in prefrontal cortex indicated that similar to hippocampus, Nrf2 knockdown caused a notably increase in CS activity. In contrary to hippocampus, increase in activity of CS in prefrontal cortex had upward trend 8 h after siRNA injection. While activity of MDH in this region of brain significantly decreased compared to control rats 8 h after siRNA injection, the activity of MDH did not show any significant change 4 h after Nrf2 silencing in comparison with control rats (Fig. 4C and 4D ). Unlike the hippocampus and prefrontal cortex, our data revealed that activity of two enzymes CS and MDH did not significantly change following Nrf2 silencing in amygdala compared to the control group 4 and 8 h after injection (Fig. 4E and 4F ). 
DISSCUSION
The findings presented here demonstrated that Nrf2 knockdown led to a significant reduction in PGC-1α levels in three brain regions including hippocampus, amygdala and prefrontal cortex. However, there was no significant alteration in protein level of NRF-1, TFAM and cytochrome c in three desired regions. Moreover, these alterations were accompanied with changes in activities of specific enzymes of TCA cycle following Nrf2 knockdown. Obtained data from biochemical analysis revealed that Nrf2 knockdown increased CS activity in hippocampus and prefrontal cortex but not in amygdala. Besides, MDH activity notably decreased in hippocampus and prefrontal cortex but not in amygdala following Nrf2 knockdown. A recent work from our laboratory has revealed that intraventricular administration of siRNA targeting Nrf2 exerted significant anxiety-like behavior in rats besides mitochondrial dysfunction and neuronal apoptosis in hippocampus, amygdala, and prefrontal cortex (18) . Accordingly, the original aim of the present report was to check whether Nrf2 silencing could affect another feature of mitochondrial network quality control including mitochondrial biogenesis. Based on our findings, whilst PGC-1α as a central stimulator of mitochondrial biogenesis significantly downregulated by Nrf2 knockdown, its downstream molecules including NRF-1 and TFAM was not notably influenced by Nrf2 silencing. One of the main reasons for this reduction in PGC-1α protein level could be attributed to the crucial role of Nrf2 in PGC-1α activation. As hypothesized by Clark and Simon, there are Nrf2 consensus sequences in PGC-1α promoter that makes a redox regulatory loop between PGC-1α and Nrf2 expression (19) . In this line, it has been shown that first 2 Kb of PGC-1α promoter has two ARE core sequences (20) . Moreover, Adamovich et al. (21) have reported that NAD(P)H dehydrogenase [quinone] 1 (NQO1) which is a Nrf2-dependent downstream, has leading role in regulation of PGC-1α activity by means of protecting PGC-1α from proteasomal degradation in NADH-dependent manner. In this regard, we have reported previously (13) that as a compensatory response to Nrf1 silencing, protein level of Nrf2 increased in three regions hippocampus, amygdala and prefrontal cortex which was accompanied by elevated level of PGC-1α following intraventricular injection of Nrf1-siRNA. It seems that due to the Nrf2 response sequences in PGC-1α promoter, Nrf2 knockdown leads to downregulation of PGC-1α. Neurons are the most highly glucose consuming cells to maintain their intrinsic functions (22) . According to the importance of energy metabolism in neuronal cells, TCA cycle which include eight crucial enzymes could reflect the cerebral metabolism rate. In fact, TCA cycle as the core part of the aerobic respiration in cells includes a series of enzyme-catalyzed chemical reactions starting from CS and ending to MDH enzymes (23) . Based on the main role of TCA cycle in glucose metabolism, we examined the activity of CS and MDH enzymes of the cycle following Nrf2 knockdown. Our data from biochemical analysis indicated that activity of CS increased in prefrontal cortex and hippocampus, while MDH enzyme activity decreased in those regions following Nrf2 silencing. The exact mechanism underling Nrf2 knockdown exerts its effects on TCA cycle enzymes activity remain unknown. However, it has been documented that Nrf2 participates in anabolic pathways of glucose and glutamine metabolisms (22) (23) (24) (25) (26) . Hence, it could be supposed that Nrf2 silencing leads to intensify intracellular catabolism pathways ultimately, resulted in elevated level of acetyl CoA. Acetyl CoA is one of the main substrates for CS activity (25) . Furthermore, Wright et al. (26) have reported that PGC-1α may mediate activity of CS enzyme. Finally, our findings indicated that MDH activity reduced following Nrf2 silencing. In addition to regulatory effect of Nrf2 on MDH expression (26) (27) (28) , it has been shown that PGC-1α overexpression leads to upregulation of TCA cycle enzymes activity and expression (27) (28) (29) . Considering the significant decrease in protein level of PGC-1α in Nrf2 siRNA injected rats, it is expected that decrease in activity of MDH is due to downregulation of PGC-1α alongside Nrf2 knockdown (29, 30) . Although the exact mechanism that Nrf2 exerts its effects on mitochondrial energy homeostasis remain unknown, it is obvious that there is a cross-talk between Nrf2 and various intracellular metabolic systems. Further studies are required to clarify the direct link between Nrf2 and mitochondrial function.
CONCLUSION
In conclusion, the present findings highlighted complex interaction of Nrf2 with mitochondrial functions in a brain region-specific manner. The results of the present study suggested a specific role of Nrf2 in modulation of mitochondrial biogenesis in brain. Moreover, our data revealed that Nrf2 knockdown has contradictory effects on TCA cycle enzymes activity in hippocampus, prefrontal cortex and amygdala. However, by outlining the exact interaction between Nrf2 as the key regulator of antioxidant defense system and mitochondria as the main intracellular sources of ROS, it would be possible to find new therapeutic strategies for neurological disorders related to oxidative stress.
